Latest The Texas Heart Institute Stories
Two Turkish Hospitals and Two U.S. Centers to Complete Phase I in January Tucson, Ariz. (Vocus/PRWEB) January 20, 2011 On Jan. 20, SynCardia Systems, Inc.
ALLENDALE, N.J., Dec. 21, 2010 /PRNewswire/ -- The American Heart Journal today reported results of a clinical trial evaluating Amorcyte, Inc.'s lead product candidate, AMR-001 for the treatment of damaged heart muscle following acute myocardial infarction (AMI).
Texans For Stem Cell Research Event Brings International Biomedical Science Leaders to Austin October 27th - Free and Open to Public.
Texans For Stem Cell Research Event Brings International Biomedical Science Leaders to Austin October 27th - Free and Open to Public Texans for Stem Cell Research (TCSR), a non-profit grassroots organization, announces an educational event about stem cell research and advances in their first Annual Learn and Live Educational Series, at the University of Texas Joe C.
SAN DIEGO, Sept. 14 /PRNewswire/ -- The 14th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) will feature a discussion titled "Latest Developments in Stem Cell and Gene Therapy in Heart Failure" which includes a presentation by Dr.
A state-of-the-art heart pump recently approved for use in end-stage cardiac patients has a significantly lower risk for infection than an earlier model of the device.
University of Utah heart surgeon implants VAD in Idaho man as part of national clinical trial.
HOUSTON, March 10 /PRNewswire-USNewswire/ -- Charles D. Fraser, Jr., M.D., an internationally recognized leader in pediatric and congenital heart surgery, has been appointed surgeon-in-chief at Texas Children's Hospital in Houston, effective July 1.
WAYNE, N.J., Jan.
Device Provides Support for Those Who Are Not Acceptable Transplant Candidates SILVER SPRING, Md., Jan. 20 /PRNewswire-USNewswire/ -- The U.S.
- A transitional zone between two communities containing the characteristic species of each.